Caveolin-1, caveolae, and glioblastoma

Neuro-Oncology

Volumn 14, Issue 6, 2012, Pages 679-688

  Parat, Marie Odile ^a   Riggins, Gregory J ^b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

caveolae; caveolin 1; EGF receptor; glioblastoma; uPA

Indexed keywords

CAVEOLIN 1; COLLAGEN TYPE 1; EPIDERMAL GROWTH FACTOR RECEPTOR; GELATINASE A; GELATINASE B; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE;

ASTROCYTE; CANCER CELL; CANCER CLASSIFICATION; CANCER GROWTH; CANCER INVASION; CANCER PROGNOSIS; CAVEOLA; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; GLIOBLASTOMA; HUMAN; INTRACELLULAR SIGNALING; MOLECULARLY TARGETED THERAPY; MULTIDRUG RESISTANCE; NONHUMAN; ONCOGENE; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; TUMOR SUPPRESSOR GENE; UPREGULATION;

ANIMALS; CAVEOLAE; CAVEOLIN 1; GLIOBLASTOMA; HUMANS; MEMBRANE MICRODOMAINS;

EID: 84862203998     PISSN: 15228517     EISSN: 15235866     Source Type: Journal    
DOI: 10.1093/neuonc/nos079     Document Type: Review

References (104)

1. Parat MO. The biology of caveolae: achievements and perspectives. Int Rev Cell Mol Biol. 2009;273:117-162.
2. Hill MM, Bastiani M, Luetterforst R, et al. PTRF-Cavin, a Conserved Cytoplasmic Protein Required for Caveola Formation and Function. Cell. 2008;132(1):113-124.
3. Hayer A, Stoeber M, Bissig C, Helenius A. Biogenesis of Caveolae: Stepwise Assembly of Large Caveolin and Cavin Complexes. Traffic. 2010;11(3):361-382.
4. Dietzen DJ, Hastings WR, Lublin DM. Caveolin is palmitoylated on multiple cysteine residues. Palmitoylation is not necessary for localization of caveolin to caveolae. J Biol Chem. 1995;270:6838-6842.
5. Epand RM, Sayer BG, Epand RF. Caveolin Scaffolding Region and Cholesterol-rich Domains in Membranes. Journal of Molecular Biology. 2005;345(2):339-350. (Pubitemid 39574855)
6. Couet J, Li S, Okamoto T, Ikezu T, Lisanti MP. Identification of peptide and protein ligands for the caveolin-scaffolding domain. Implications for the interaction of caveolin with caveolae-associated proteins. J Biol Chem. 1997;272:6525-6533. (Pubitemid 27118133)
7. Schlegel A, Arvan P, Lisanti MP. Caveolin-1 binding to endoplasmic reticulum membranes and entry into the regulated secretory pathway are regulated by serine phosphorylation. Protein sorting at the level of the endoplasmic reticulum. J Biol Chem. 2001;276(6):4398-4408.
8. Glenney JR, Jr. Tyrosine phosphorylation of a 22-kDa protein is correlated with transformation by Rous sarcoma virus. J Biol Chem. 1989;264:20163-20166. (Pubitemid 20009187)
9. van Golen KL. Is caveolin-1 a viable therapeutic target to reduce cancer metastasis? Expert Opin Ther Targets. 2006;10(5):709-721. (Pubitemid 44479979)
10. Thompson TC, Tahir SA, Li L, et al. The role of caveolin-1 in prostate cancer: clinical implications. Prostate Cancer Prostatic Dis. 2010;13(1):6-11.
11. Williams TM, Lisanti MP. Caveolin-1 in oncogenic transformation, cancer, and metastasis. Am J Physiol Cell Physiol. 2005;288(3):C494-C506. (Pubitemid 40229478)
12. Goetz J, Lajoie P, Wiseman S, Nabi I. Caveolin-1 in tumor progression: the good, the bad and the ugly. Cancer and Metastasis Reviews. 2008;27(4):715-735.
13. Engelman JA, Zhang XL, Lisanti MP. Genes encoding human caveolin-1 and-2 are co-localized to the D7S522 locus (7q31.1), a known fragile site (FRA7G) that is frequently deleted in human cancers. FEBS Lett. 1998;436:403-410. (Pubitemid 28482971)
14. Tahir SA, Ren C, Timme TL, et al. Development of an immunoassay for serum caveolin-1: a novel biomarker for prostate cancer. Clin Cancer Res. 2003;9(10, pt 1):3653-3659. (Pubitemid 37169231)
15. Tahir SA, Yang G, Ebara S, et al. Secreted caveolin-1 stimulates cell survival/clonal growth and contributes to metastasis in androgeninsensitive prostate cancer. Cancer Res. 2001;61(10):3882-3885. (Pubitemid 32720945)
16. Tahir SA, Yang G, Goltsov AA, et al. Tumor cell-secreted caveolin-1 has proangiogenic activities in prostate cancer. Cancer Res. 2008;68(3):731-739. (Pubitemid 351206749)
17. Goetz JG, Minguet S, Navarro-Lerida I, et al. Biomechanical remodeling of the microenvironment by stromal caveolin-1 favors tumor invasion and metastasis. Cell. 2011;146(1):148-163.
18. HillMM, ParatMO, PartonRG, Soon LeeC.Clearing the confusion ofCav1 and caveolae in cancer compartments. Comment on: Cell 2011;146(1), 148-163. Cell http://www.cell.com/abstract/S0092-8674%2811% 2900645-3#Comments. 2011. Ref Type: Internet Communication.
19. Aung CS, Hill MM, Bastiani M, Parton RG, Parat MO. PTRF-cavin-1 expression decreases the migration of PC3 prostate cancer cells: Role of matrix metalloprotease 9. Eur J Cell Biol. 2010;90:136-142.
20. Steffens S, Schrader A, Blasig H, et al. Caveolin 1 protein expression in renal cell carcinoma predicts survival. BMC Urology. 2011;11(1):25.
21. Bastiani M, Liu L, Hill MM, et al. MURC/Cavin-4 and cavin family members form tissue-specific caveolar complexes. J Cell Biol. 2009;185(7):1259-1273.
22. Jansa P, Grummt I. Mechanism of transcription termination: PTRF interacts with the largest subunit of RNA polymerase I and dissociates paused transcription complexes from yeast and mouse. Mol Gen Genet. 1999;262(3):508-514. (Pubitemid 29535293)
23. Jansa P, Mason SW, Hoffmann-Rohrer U, Grummt I. Cloning and functional characterization of PTRF, a novel protein which induces dissociation of paused ternary transcription complexes. EMBO J. 1998;17(10):2855-2864. (Pubitemid 28227132)
24. Hasegawa T, Takeuchi A, Miyaishi O, Xiao H, Mao J, Isobe K. PTRF (polymerase I and transcript-release factor) is tissue-specific and interacts with the BFCOL1 (binding factor of a type-I collagen promoter) zinc-finger transcription factor which binds to the two mouse type-I collagen gene promoters. Biochem J. 2000;347(pt 1):55-59. (Pubitemid 30199040)
25. Hansen CG, Bright NA, Howard G, Nichols BJ. SDPR induces membrane curvature and functions in the formation of caveolae. Nat Cell Biol. 2009;11(7):807-814.
26. McMahon KA, Zajicek H, Li WP, et al. SRBC/cavin-3 is a caveolin adapter protein that regulates caveolae function. EMBO J. 2009;28(8):1001-1015.
27. Bai L, Deng X, Li Q, et al. Down-regulation of the cavin family proteins in breast cancer. J Cell Biochem. 2012;113(1):322-328.
28. Gould ML, Williams G, Nicholson HD. Changes in caveolae, caveolin, and polymerase 1 and transcript release factor (PTRF) expression in prostate cancer progression. Prostate. 2010;70(15):1609-1621.
29. Inder KL, Zheng YZ, Davis MJ, et al. Expression of PTRF in PC-3 cells modulates cholesterol dynamics and the actin cytoskeleton impacting secretion pathways. Molecular & Cellular Proteomics. 2012;11(1): 119-131.
30. Allen WL, Stevenson L, Coyle VM, et al. A Systems Biology Approach Identifies SART1 as a Novel Determinant of Both 5-Fluorouracil and SN38 Drug Resistance in Colorectal Cancer. Molecular Cancer Therapeutics. 2012;11(2):M111-012245.
31. Guha U, Chaerkady R, Marimuthu A, et al. Comparisons of tyrosine phosphorylated proteins in cells expressing lung cancer-specific alleles of EGFR and KRAS. PNAS. 2008;105(37):14112-14117.
32. Mineo C, James GL, Smart EJ, Anderson RG. Localization of epidermal growth factor-stimulated Ras/Raf-1 interaction to caveolae membrane. J Biol Chem. 1996;271:11930-11935. (Pubitemid 26157268)
33. Couet J, Sargiacomo M, Lisanti MP. Interaction of a receptor tyrosine kinase, EGF-R, with caveolins. Caveolin binding negatively regulates tyrosine and serine/threonine kinase activities. J Biol Chem. 1997;272:30429-30438. (Pubitemid 27512253)
34. Engelman JA, Chu C, Lin A, et al. Caveolin-mediated regulation of signaling along the p42/44 MAP kinase cascade in vivo. A role for the caveolin-scaffolding domain. FEBS Lett. 1998;428:205-211. (Pubitemid 28319685)
35. Ringerike T, Blystad FD, Levy FO, Madshus IH, Stang E. Cholesterol is important in control of EGF receptor kinase activity but EGF receptors are not concentrated in caveolae. J Cell Sci. 2002;115(6): 1331-1340. (Pubitemid 34272497)
36. Sbaa E, Frerart F, Feron O. The double regulation of endothelial nitric oxide synthase by caveolae and caveolin: a paradox solved through the study of angiogenesis. Trends Cardiovasc Med. 2005;15(5):157-162. (Pubitemid 41297625)
37. Hill MM, Scherbakov N, Schiefermeier N, et al. Reassessing the role of phosphocaveolin-1 in cell adhesion and migration. Traffic. 2007;8(12):1695-1705. (Pubitemid 350066682)
38. Parat MO, Anand-Apte B, Fox PL. Differential caveolin-1 polarization in endothelial cells during migration in two and three dimensions. Mol Biol Cell. 2003;14:3156-3168. (Pubitemid 37013117)
39. Santilman V, Baran J, Anand-Apte B, Evans RM, Parat MO. Caveolin-1 polarization in transmigrating endothelial cells requires binding to intermediate filaments. Angiogenesis. 2007;10(4):297-305. (Pubitemid 350045886)
40. Lee H, Volonte D, Galbiati F, et al. Constitutive and growth factorregulated phosphorylation of caveolin-1 occurs at the same site (Tyr-14) in vivo: identification of a c-Src/Cav-1/Grb7 signaling cassette. Mol Endocrinol. 2000;14(11):1750-1775.
41. Cao H, Courchesne WE, Mastick CC. A phosphotyrosine-dependent protein interaction screen reveals a role for phosphorylation of caveolin-1 on tyrosine 14: recruitment of C-terminal Src kinase. J Biol Chem. 2002;277(11):8771-8774. (Pubitemid 34952941)
42. Gaus K, Le LS, Balasubramanian N, Schwartz MA. Integrin-mediated adhesion regulates membrane order. J Cell Biol. 2006;174(5): 725-734. (Pubitemid 44306728)
43. Goetz JG, Joshi B, Lajoie P, et al. Concerted regulation of focal adhesion dynamics by galectin-3 and tyrosine-phosphorylated caveolin-1. J Cell Biol. 2008;130(6):1261-1273.
44. Radel C, Rizzo V. Integrin mechanotransduction stimulates caveolin-1 phosphorylation and recruitment of Csk to mediate actin reorganization. Am J Physiol Heart Circ Physiol. 2005;288(2):H936-H945. (Pubitemid 40139682)
45. del Pozo MA, Balasubramanian N, Alderson NB, et al. Phospho-caveolin-1 mediates integrin-regulated membrane domain internalization. Nat Cell Biol. 2005;7(9):901-908. (Pubitemid 41486291)
46. Galbiati F, Volonte D, Gil O, et al. Expression of caveolin-1 and-2 in differentiating PC12 cells and dorsal root ganglion neurons: caveolin-2 is up-regulated in response to cell injury. Proc Natl Acad Sci USA. 1998;95:10257-10262.
47. Massa PT. Plasmalemmal vesicles (caveolae) of fibrous astrocytes of the cat optic nerve. Am J Anat. 1982;165(1):69-81. (Pubitemid 12009525)
48. Lawrence JM, Raisman G. Membrane specializations and extracellular material associated with host astrocytes in peripheral neural transplants. Neuroscience. 1987;20(3):1031-1041.
49. Massa PT, Mugnaini E. Cell-cell junctional interactions and characteristic plasma membrane features of cultured rat glial cells. Neuroscience. 1985;14(2):695-709. (Pubitemid 15169931)
50. Cameron PL, Ruffin JW, Bollag R, Rasmussen H, Cameron RS. Identification of caveolin and caveolin-related proteins in the brain. J Neurosci. 1997;17(24):9520-9535. (Pubitemid 28006396)
51. Zschocke J, Bayatti N, Behl C. Caveolin and GLT-1 gene expression is reciprocally regulated in primary astrocytes: Association of GLT-1 with non-caveolar lipid rafts. Glia. 2005;49(2):275-287. (Pubitemid 40188505)
52. Teixeira A, Chaverot N, Schroder C, Strosberg AD, Couraud PO, Cazaubon S. Requirement of caveolae microdomains in extracellular signal-regulated kinase and focal adhesion kinase activation induced by endothelin-1 in primary astrocytes. J Neurochem. 1999;72:120-128. (Pubitemid 29013885)
53. Yun JH, Park SJ, Jo A, et al. Caveolin-1 is involved in reactive oxygen species-induced SHP-2 activation in astrocytes. Exp Mol Med. 2011; 43(12):660-668.
54. Weerth SH, Holtzclaw LA, Russell JT. Signaling proteins in raft-like microdomains are essential for Ca2+ wave propagation in glial cells. Cell Calcium. 2007;41(2):155-167. (Pubitemid 44964458)
55. Blanco AM, Perez-Arago A, Fernandez-Lizarbe S, Guerri C. Ethanol mimics ligand-mediated activation and endocytosis of IL-1RI/TLR4 receptors via lipid rafts caveolae in astroglial cells. Journal of Neurochemistry. 2008;106(2):625-639.
56. Ronaldson PT, Bendayan M, Gingras D, Piquette-Miller M, Bendayan R. Cellular localization and functional expression of P-glycoprotein in rat astrocyte cultures. Journal of Neurochemistry. 2004;89(3): 788-800. (Pubitemid 38534163)
57. Megias L, Guerri C, Fornas E, et al. Endocytosis and transcytosis in growing astrocytes in primary culture. Possible implications in neural development. Int J Dev Biol. 2000;44(2):209-221. (Pubitemid 30190757)
58. Bento-Abreu A, Velasco A, Polo-Herná ndez E, et al. Albumin endocytosis via megalin in astrocytes is caveola-and Dab-1 dependent and is required for the synthesis of the neurotrophic factor oleic acid. Journal of Neurochemistry. 2009;111(1):49-60.
59. Andjelkovic AV, Song L, Dzenko KA, Cong H, Pachter JS. Functional expression of CCR2 by human fetal astrocytes. Journal of Neuroscience Research. 2002;70(2):219-231.
60. Ge S, Pachter JS. Caveolin-1 knockdown by small interfering RNA suppresses responses to the chemokine MCP-1 by human astrocytes. J Biol Chem. 2004;279(8):6688-6695. (Pubitemid 38248808)
61. Gonzalez MI, Krizman-Genda E, Robinson MB. Caveolin-1 Regulates the Delivery and Endocytosis of the Glutamate Transporter, Excitatory Amino Acid Carrier 1. Journal of Biological Chemistry. 2007;282(41):29855-29865. (Pubitemid 350035272)
62. Ito J, Nagayasu Y, Kato K, Sato R, Yokoyama S. Apolipoprotein A-I Induces Translocation of Cholesterol, Phospholipid, and Caveolin-1 to Cytosol in Rat Astrocytes. Journal of Biological Chemistry. 2002;277(10):7929-7935. (Pubitemid 34968243)
63. Igbavboa U, Sun GY, Weisman GA, He Y, Wood WG. Amyloid betaprotein stimulates trafficking of cholesterol and caveolin-1 from the plasma membrane to the Golgi complex in mouse primary astrocytes. Neuroscience. 2009;162(2):328-338.
64. Ahn M, Kim H, Kim JT, et al. Gamma-ray irradiation stimulates the expression of caveolin-1 and GFAP in rat spinal cord: a study of immunoblot and immunohistochemistry. J Vet Sci. 2006;7(4):309-314. (Pubitemid 44885828)
65. Alves TR, Lima FRS, Kahn SA, et al. Glioblastoma cells: A heterogeneous and fatal tumor interacting with the parenchyma. Life Sciences. 2011;89(15-16):532-539.
66. Cassoni P, Senetta R, Castellano I, et al. Caveolin-1 Expression is Variably Displayed in Astroglial-derived Tumors and Absent in Oligodendrogliomas: Concrete Premises for a New Reliable Diagnostic Marker in Gliomas. The American Journal of Surgical Pathology. 2007;31(5):760-769. (Pubitemid 46684217)
67. Barresi V, Buttarelli FR, Vitarelli E E, Arcella A, Antonelli M, Giangaspero F. Caveolin-1 expression in diffuse gliomas: correlation with the proliferation index, epidermal growth factor receptor, p53, and 1p/19q status. Human Pathology. 2009;40(12):1738-1746.
68. Sallinen SL, Sallinen PK, Haapasalo HK, et al. Identification of differentially expressed genes in human gliomas by DNA microarray and tissue chip techniques. Cancer Res. 2000;60(23):6617-6622.
69. Abulrob A, Giuseppin S, Andrade MF, McDermid A, Moreno M, Stanimirovic D. Interactions of EGFR and caveolin-1 in human glioblastoma cells: evidence that tyrosine phosphorylation regulates EGFR association with caveolae. Oncogene. 2004;23(41):6967-6979. (Pubitemid 39279997)
70. Cameron PL, Liu C, Smart DK, Hantus ST, Fick JR, Cameron RS. Caveolin-1 expression is maintained in rat and human astroglioma cell lines. Glia. 2002;37(3):275-290.
71. Ludwig HC, Rausch S, Schallock K, Markakis E. Expression of CD 73 (ecto-5′-nucleotidase) in 165 glioblastomas by immunohistochemistry and electronmicroscopic histochemistry. Anticancer Res. 1999;19(3A):1747-1752. (Pubitemid 29392731)
72. Perez AP, Cosaka ML, Romero EL, Morilla MJ. Uptake and intracellular traffic of siRNA dendriplexes in glioblastoma cells and macrophages. Int J Nanomedicine. 2011;6:2715-2728.
73. Chung WJ, Lyons SA, Nelson GM, et al. Inhibition of cystine uptake disrupts the growth of primary brain tumors. J Neurosci. 2005;25(31):7101-7110. (Pubitemid 41113926)
74. Chen RS, Song YM, Zhou ZY, et al. Disruption of xCT inhibits cancer cell metastasis via the caveolin-1/[beta]-catenin pathway. Oncogene. 2008;28(4):599-609.
75. Bruyere C, Abeloos L, Lamoral-Theys D, et al. Temozolomide modifies caveolin-1 expression in experimental malignant gliomas in vitro and in vivo. Transl Oncol. 2011;4(2):92-100.
76. Zhu H, Yue J, Pan Z, et al. Involvement of Caveolin-1 in Repair of DNA Damage through Both Homologous Recombination and Non-Homologous End Joining. PLoS ONE. 2010;5(8):e12055.
77. Martin S, Cosset EC, Terrand J, Maglott A, Takeda K, Dontenwill M. Caveolin-1 regulates glioblastoma aggressiveness through the control of alpha(5)beta(1) integrin expression and modulates glioblastoma responsiveness to SJ749, an alpha(5)beta(1) integrin antagonist. Biochimica et Biophysica Acta (BBA)-Molecular Cell Research. 2009;1793(2):354-367.
78. Mineo C, GillGN,AndersonRG. RegulatedMigration of Epidermal Growth Factor Receptor from Caveolae. J Biol Chem. 1999;274:30636-30643.
79. Nishikawa R, Ji XD, Harmon RC, et al. A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity. PNAS. 1994;91(16):7727-7731. (Pubitemid 24238258)
80. Bomben VC, Turner KL, Barclay TT, Sontheimer H. Transient receptor potential canonical channels are essential for chemotactic migration of human malignant gliomas. Journal of Cellular Physiology. 2011;226(7):1879-1888.
81. Wu H, Mahmood A, Lu D, et al. Attenuation of astrogliosis and modulation of endothelial growth factor receptor in lipid rafts by simvastatin after traumatic brain injury. Journal of Neurosurgery. 2009;113(3):591-597.
82. Le DM, Besson A, Fogg DK, et al. Exploitation of astrocytes by glioma cells to facilitate invasiveness: a mechanism involving matrix metalloproteinase-2 and the urokinase-type plasminogen activatorplasmin cascade. J Neurosci. 2003;23(10):4034-4043. (Pubitemid 36958422)
83. Lakka SS, Gondi CS, Dinh DH, et al. Specific Interference of Urokinase-type Plasminogen Activator Receptor and Matrix Metalloproteinase-9 Gene Expression Induced by Double-stranded RNA Results in Decreased Invasion, Tumor Growth, and Angiogenesis in Gliomas. Journal of Biological Chemistry. 2005;280(23):21882-21892. (Pubitemid 40827839)
84. Salajegheh M, Rudnicki A, Smith TW. Expression of urokinase-type plasminogen activator receptor (uPAR) in primary central nervous system neoplasms. Appl Immunohistochem Mol Morphol. 2005;13(2):184-189. (Pubitemid 40726857)
85. Chapman HA, Wei Y, Simon DI, Waltz DA. Role of urokinase receptor and caveolin in regulation of integrin signaling. Thromb Haemost. 1999;82(2):291-297.
86. Wary KK, Mariotti A, Zurzolo C, Giancotti FG. A requirement for caveolin-1 and associated kinase Fyn in integrin signaling and anchorage-dependent cell growth. Cell. 1998;94:625-634. (Pubitemid 28427581)
87. Monaghan-Benson E, Keown-Longo PJ. Urokinase-type Plasminogen Activator Receptor Regulates a Novel Pathway of Fibronectin Matrix Assembly Requiring Src-dependent Transactivation of Epidermal Growth Factor Receptor. Journal of Biological Chemistry. 2006;281(14):9450-9459. (Pubitemid 43864662)
88. Monaghan-Benson E, Mastick CC, Keown-Longo PJ. A dual role for caveolin-1 in the regulation of fibronectin matrix assembly by uPAR. J Cell Sci. 2008;121(22):3693-3703.
89. Preissner KT, Kanse SM, May AE. Urokinase receptor: a molecular organizer in cellular communication. CurrOpin Cell Biol. 2000;12(5):621-628.
90. Chandrasekar N, Mohanam S, Gujrati M, Olivero WC, Dinh DH, Rao JS. Downregulation of uPA inhibits migration and PI3k/Akt signaling in glioblastoma cells. Oncogene. 2003;22(3):392-400. (Pubitemid 36194335)
91. Raghu H, Gondi C, Dinh D, Gujrati M, Rao J. Specific knockdown of uPA/uPAR attenuates invasion in glioblastoma cells and xenografts by inhibition of cleavage and trafficking of Notch-1 receptor. Molecular Cancer. 2011;10(1):130.
92. Hu J, Jo M, Cavenee WK, Furnari F, VandenBerg SR, Gonias SL. Crosstalk between the urokinase-type plasminogen activator receptor and EGF receptor variant III supports survival and growth of glioblastoma cells. PNAS. 2011;108(38):15984-15989.
93. Fillmore HL, VanMeter TE, Broaddus WC. Membrane-type Matrix Metalloproteinases (MT-MMP)s: Expression and Function During Glioma Invasion. Journal of Neuro-Oncology. 2001;53(2):187-202. (Pubitemid 33034691)
94. Deryugina EI, Bourdon MA, Luo GX, Reisfeld RA, Strongin A. Matrix metalloproteinase-2 activation modulates glioma cell migration. J Cell Sci. 1997;110(19):2473-2482. (Pubitemid 127699161)
95. Annabi B, Lachambre M, Bousquet-Gagnon N, Page M, Gingras D, Beliveau R. Localization of membrane-type 1 matrix metalloproteinase in caveolae membrane domains. Biochem J. 2001;353(pt 3):547-553. (Pubitemid 32158323)
96. Labrecque L, Nyalendo C, Langlois S, et al. Src-mediated Tyrosine Phosphorylation of Caveolin-1 Induces Its Association with Membrane Type 1 Matrix Metalloproteinase. J Biol Chem. 2004;279(50):52132-52140. (Pubitemid 39656586)
97. Jodoin J, Demeule M, Fenart L, et al. P-glycoprotein in blood-brain barrier endothelial cells: interaction and oligomerization with caveolins. Journal of Neurochemistry. 2003;87(4):1010-1023. (Pubitemid 37444575)
98. Golden PL, Pardridge WM. P-glycoprotein on astrocyte foot processes of unfixed isolated human brain capillaries. Brain Research. 1999;819(1-2):143-146. (Pubitemid 29225465)
99. Bendayan R, Ronaldson PT, Gingras D, Bendayan M. In Situ Localization of P-glycoprotein (ABCB1) in Human and Rat Brain. Journal of Histochemistry & Cytochemistry. 2006;54(10):1159-1167. (Pubitemid 44434719)
100. Guo Z, Zhu J, Zhao L, Luo Q, Jin X. Expression and clinical significance of multidrug resistance proteins in brain tumors. J Exp Clin Cancer Res. 2010;29:122.
101. Bucci M, Gratton JP, Rudic RD, et al. In vivo delivery of the caveolin-1 scaffolding domain inhibits nitric oxide synthesis and reduces inflammation. Nat Med. 2000;6(12):1362-1367. (Pubitemid 32001020)
102. Schmitz M, Zerr I, Althaus H. Effect of Cavtratin, a Caveolin-1 Scaffolding Domain Peptide, on Oligodendroglial Signaling Cascades. Cellular and Molecular Neurobiology. 2011;31(7):991-997.
103. Bernatchez P, Sharma A, Bauer PM, Marin E, Sessa WC. A noninhibitory mutant of the caveolin-1 scaffolding domain enhances eNOS-derived NO synthesis and vasodilation in mice. J Clin Invest. 2011;121(9):3747-3755.
104. Forget MA, Desrosiers RR, Del Maestro RF, et al. The expression of Rho proteins decreases with human brain tumor progression: Potential tumor markers. Clinical and Experimental Metastasis. 2002;19(1): 9-15. (Pubitemid 34208349)